Taking Ozempic or Wegovy? The FDA says there’s a new warning you shouldn’t ignore

The FDA is adding a new warning label onto GLP-1 drugs like Ozempic and Zepbound for a rare side effect with serious risk. All GLP-1 drug makers will now be required to include new safety warnings informing patients that the medications could increase risk of sudden vision loss from a condition known as nonarteritic anterior ischemic optic neuropathy (NAION). The condition, which is not common, can lead to sudden decreased vision in one eye and even permanent vision loss. The condition’...